Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 3345

1.

High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.

Lugoboni F, Mirijello A, Zamboni L, Faccini M, Casari R, Cossari A, Gasbarrini A, Addolorato G, On Behalf Of Gics.

Expert Opin Pharmacother. 2016 Nov;17(16):2135-2141.

PMID:
27603712
2.

Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients.

Huang MW, Chiang TA, Lo PY, Huang CS.

Behav Brain Funct. 2016 Aug 31;12(1):24. doi: 10.1186/s12993-016-0109-9.

3.

Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Gladden RM, Martinez P, Seth P.

MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):837-43. doi: 10.15585/mmwr.mm6533a2.

4.

Chronic Treatment with Opiate Agonists in Bulgaria - Assessing the Quality of Life Using SF 36 v. 2.

Petrov SV, Orbetzova MM, Iliev YT, Boyadzhiev DT.

Folia Med (Plovdiv). 2016 Apr-Jun;58(2):115-21. doi: 10.1515/folmed-2016-0019.

PMID:
27552788
5.

Regional homogeneity changes between heroin relapse and non-relapse patients under methadone maintenance treatment: a resting-state fMRI study.

Chang H, Li W, Li Q, Chen J, Zhu J, Ye J, Liu J, Li Z, Li Y, Shi M, Wang Y, Wang W.

BMC Neurol. 2016 Aug 18;16(1):145. doi: 10.1186/s12883-016-0659-3.

6.

[Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013].

Gentile G, Frauger E, Giocanti A, Pauly V, Orleans V, Amaslidou D, Thirion X, Micallef J; Réseau national des centres d’addictovigilance..

Therapie. 2016 Jun;71(3):307-13. doi: 10.1016/j.therap.2016.02.001. French.

PMID:
27235654
7.

[Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan].

Zhou Y, Luo W, Cao XB, Zhang B, Wu ZY.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 May;37(5):648-52. doi: 10.3760/cma.j.issn.0254-6450.2016.05.012. Chinese.

PMID:
27188355
8.

Opioid agonist treatment for pharmaceutical opioid dependent people.

Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N.

Cochrane Database Syst Rev. 2016 May 9;(5):CD011117. doi: 10.1002/14651858.CD011117.pub2. Review.

PMID:
27157143
9.

[Does substitution with heroin make sense?].

Stiefelhagen P.

MMW Fortschr Med. 2016 May 12;158(9):12. doi: 10.1007/s15006-016-8175-3. German. No abstract available.

PMID:
27155680
10.

Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell M, Ali R, White JM.

Cochrane Database Syst Rev. 2016 May 3;(5):CD002024. doi: 10.1002/14651858.CD002024.pub5. Review.

PMID:
27140827
11.

The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.

Walcher S, Koc J, Reichel V, Schlote F, Verthein U, Reimer J.

BMC Pharmacol Toxicol. 2016 Apr 7;17:15. doi: 10.1186/s40360-016-0058-9.

12.

Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men.

Sheynin J, Moustafa AA, Beck KD, Servatius RJ, Casbolt PA, Haber P, Elsayed M, Hogarth L, Myers CE.

J Clin Psychiatry. 2016 Mar;77(3):386-94. doi: 10.4088/JCP.14m09284.

13.

Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania.

Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, McCurdy S, Mbwambo J, Lambdin BH.

Int J Drug Policy. 2016 Apr;30:74-81. doi: 10.1016/j.drugpo.2016.03.005.

PMID:
27017376
14.

Elevated Hair Cortisol Levels among Heroin Addicts on Current Methadone Maintenance Compared to Controls.

Yang J, Li J, Xu G, Zhang J, Chen Z, Lu Z, Deng H.

PLoS One. 2016 Mar 24;11(3):e0150729. doi: 10.1371/journal.pone.0150729.

16.

US pledges better protection for babies born to addicts.

Dyer O.

BMJ. 2016 Mar 22;352:i1679. doi: 10.1136/bmj.i1679. No abstract available.

PMID:
27006012
17.

Concurrent Heroin Use and Correlates among Methadone Maintenance Treatment Clients: A 12-Month Follow-up Study in Guangdong Province, China.

Luo X, Zhao P, Gong X, Zhang L, Tang W, Zou X, Chen W, Ling L.

Int J Environ Res Public Health. 2016 Mar 9;13(3). pii: E305. doi: 10.3390/ijerph13030305.

18.

Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.

Zhang B, Cai T, Yan Z, Mburu G, Wang B, Yang L.

Harm Reduct J. 2016 Feb 26;13:8. doi: 10.1186/s12954-016-0097-y.

19.

Towards "evidence-making intervention" approaches in the social science of implementation science: The making of methadone in East Africa.

Rhodes T, Closson EF, Paparini S, Guise A, Strathdee S.

Int J Drug Policy. 2016 Apr;30:17-26. doi: 10.1016/j.drugpo.2016.01.002.

PMID:
26905934
20.

Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.

Zamudio-Haas S, Mahenge B, Saleem H, Mbwambo J, Lambdin BH.

Int J Drug Policy. 2016 Apr;30:43-51. doi: 10.1016/j.drugpo.2016.01.012.

Items per page

Supplemental Content

Loading ...
Support Center